CorMedix (CRMD) News Today → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free CRMD Stock Alerts $5.12 -0.08 (-1.54%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 3:58 AM | americanbankingnews.comCorMedix Inc. (NASDAQ:CRMD) Short Interest Up 5.1% in AprilMay 15, 2024 | americanbankingnews.comNeedham & Company LLC Reaffirms Buy Rating for CorMedix (NASDAQ:CRMD)May 13, 2024 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call TranscriptMay 13, 2024 | marketbeat.comCorMedix's (CRMD) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $10.00 target price on shares of CorMedix in a research report on Monday.May 10, 2024 | finance.yahoo.comCorMedix Inc. (CRMD) Q1 2024 Earnings: Net Loss Widens, Misses Analyst ForecastsMay 10, 2024 | globenewswire.comCorMedix Inc. to Participate in Two Upcoming Investor ConferencesMay 9, 2024 | msn.comCRMD Stock Earnings: Cormedix Beats EPS for Q1 2024May 9, 2024 | globenewswire.comCorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 7, 2024 | marketbeat.comCorMedix (CRMD) Scheduled to Post Quarterly Earnings on ThursdayCorMedix (NASDAQ:CRMD) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 6, 2024 | globenewswire.comCorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024April 30, 2024 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Sees Significant Growth in Short InterestCorMedix Inc. (NASDAQ:CRMD - Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 9,380,000 shares, a growth of 13.7% from the March 31st total of 8,250,000 shares. Based on an average daily volume of 587,000 shares, the days-to-cover ratio is presently 16.0 days.April 20, 2024 | investing.comCorMedix product 'DefenCath' gains CMS transitional payment statusApril 20, 2024 | finanznachrichten.deCorMedix, Inc.: CorMedix Inc. Announces CMS Grants TDAPA to DefenCathApril 19, 2024 | marketwatch.comCorMedix Shares Rise 6% After DefenCath Meets Payment CriteriaApril 19, 2024 | globenewswire.comCorMedix Inc. Announces CMS Grants TDAPA to DefenCathApril 16, 2024 | marketbeat.comShort Interest in CorMedix Inc. (NASDAQ:CRMD) Increases By 6.2%CorMedix Inc. (NASDAQ:CRMD - Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 8,250,000 shares, an increase of 6.2% from the March 15th total of 7,770,000 shares. Based on an average daily trading volume, of 443,800 shares, the days-to-cover ratio is presently 18.6 days.April 15, 2024 | investorplace.comBiotech on a Budget: 7 Stocks Under $10 With Huge PotentialApril 15, 2024 | globenewswire.comCorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)April 15, 2024 | finance.yahoo.comCRMD Apr 2024 7.000 callApril 15, 2024 | finance.yahoo.comCRMD Apr 2024 8.000 putApril 11, 2024 | finance.yahoo.comCorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America ConferenceApril 11, 2024 | globenewswire.comCorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America ConferenceApril 9, 2024 | marketbeat.comCorMedix (NASDAQ:CRMD) Receives Market Outperform Rating from JMP SecuritiesJMP Securities reissued a "market outperform" rating and issued a $19.00 price objective on shares of CorMedix in a report on Tuesday.April 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)April 8, 2024 | globenewswire.comCorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLCApril 2, 2024 | finance.yahoo.comBreakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD)March 27, 2024 | finance.yahoo.comCorMedix Inc. to Present at the Needham Annual Healthcare ConferenceMarch 16, 2024 | finance.yahoo.comCRMD Apr 2024 6.000 putMarch 16, 2024 | finance.yahoo.comCRMD Apr 2024 3.000 putMarch 16, 2024 | finance.yahoo.comCRMD Apr 2024 3.000 callMarch 15, 2024 | insidertrades.comCorMedix Inc. (NASDAQ:CRMD) CEO Joseph Todisco Purchases 13,561 SharesMarch 14, 2024 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) CEO Buys $50,718.14 in StockCorMedix Inc. (NASDAQ:CRMD - Get Free Report) CEO Joseph Todisco bought 13,561 shares of CorMedix stock in a transaction that occurred on Wednesday, March 13th. The shares were acquired at an average cost of $3.74 per share, for a total transaction of $50,718.14. Following the completion of the transaction, the chief executive officer now directly owns 352,839 shares in the company, valued at $1,319,617.86. The transaction was disclosed in a filing with the SEC, which is available at this link.March 13, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on Cormedix (CRMD)March 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE)March 13, 2024 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call TranscriptMarch 13, 2024 | seekingalpha.comAyr Wellness reports mixed Q4 results; initiates Q1 FY24 outlookMarch 12, 2024 | markets.businessinsider.comBuy Rating on Cormedix Amidst DefenCath Launch and Strong Financial PositioningMarch 12, 2024 | marketwatch.comCorMedix Shares Move Lower After 4Q UpdateMarch 12, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Cormedix (CRMD), PROCEPT BioRobotics (PRCT)March 12, 2024 | msn.comCorMedix (CRMD) Q4 2023 Earnings Call TranscriptMarch 12, 2024 | finance.yahoo.comCormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities for DefenCathMarch 12, 2024 | finanznachrichten.deCorMedix, Inc.: CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 12, 2024 | sfgate.comCorMedix: Q4 Earnings SnapshotMarch 12, 2024 | globenewswire.comCorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 11, 2024 | benzinga.com6CRMD : Cormedix Earnings PreviewMarch 7, 2024 | marketbeat.comCorMedix (CRMD) Scheduled to Post Earnings on TuesdayCorMedix (NASDAQ:CRMD) will be releasing earnings before the market opens on Tuesday, March 12, Zacks reports.March 6, 2024 | globenewswire.comCorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024March 5, 2024 | marketbeat.comCorMedix (NASDAQ:CRMD) Stock Price Down 3.8%CorMedix (NASDAQ:CRMD) Stock Price Down 3.8%February 22, 2024 | benzinga.comCormedix Stock (NASDAQ:CRMD), Short Interest ReportJanuary 31, 2024 | msn.comCorMedix Announces DefenCath Launch and CMS Benefit Approval Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… CRMD Media Mentions By Week CRMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼0.620.42▲Average Medical News Sentiment CRMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼62▲CRMD Articles Average Week Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VTYX News NATR News RANI News AQST News ME News XOMA News NLTX News VNDA News INZY News URGN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
